{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:37:00Z","timestamp":1772764620859,"version":"3.50.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,21]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Piriformis syndrome (PS) is neuromuscular disorder caused by sciatic nerve compression by piriformis muscle and related to sciatic-type pain. When the conservative care fails, local injection or surgery can be also performed into piriformis. In recent years, botulinum toxin (BoNT) has also been considered as a new therapeutic option of piriformis syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A man in his late 40s came to pain clinic for left low back pain. The symptom was aggravated with sitting position.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Piriformis syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient underwent BoNT injection with 100 IU with 2\u2009mL into piriformis muscle for piriformis syndrome treatment, and his pain was relieved. However, it recurred 8 months later. BoNT injection was repeated with 100 IU with 5\u2009mL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>At the time of this writing, his pain was reduced for 2 years without any medication.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>We report a case of treating relapsed piriformis syndrome with BoNT injection of different dilution volume, suggesting that the higher the dilution volume, the more effective for therapeutic effect of BoNT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000030950","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T19:05:14Z","timestamp":1666638314000},"page":"e30950","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Botulinum toxin injection strategy of intractable and relapsed piriformis syndrome: A case report"],"prefix":"10.1097","volume":"101","author":[{"given":"So Young","family":"Kwon","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, St. Vincent Hospital, College of Medicine, The Catholic University of Korea, Suwon, South Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Hwa","family":"Jun","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, St. Vincent Hospital, College of Medicine, The Catholic University of Korea, Suwon, South Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Jin","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, St. Vincent Hospital, College of Medicine, The Catholic University of Korea, Suwon, South Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7273-8595","authenticated-orcid":false,"given":"Yumi","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, St. Vincent Hospital, College of Medicine, The Catholic University of Korea, Suwon, South Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.rehab.2013.04.003","article-title":"Piriformis muscle syndrome: diagnostic criteria and treatment of a monocentric series of 250 patients.","volume":"56","author":"Michel","year":"2013","journal-title":"Ann Phys Rehabil Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/pm\/pnx135","article-title":"Long-term efficacy of ultrasound-guided injection of incobotulinumtoxinA in piriformis syndrome.","volume":"19","author":"Rodr\u00edguez-Pi\u00f1ero","year":"2018","journal-title":"Pain Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1592\/phco.27.5.657","article-title":"Low-dose botulinum toxin type A for the treatment of refractory piriformis syndrome.","volume":"27","author":"Yoon","year":"2007","journal-title":"Pharmacotherapy"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.diii.2014.02.015","article-title":"An MRI evaluation of changes in piriformis muscle morphology induced by botulinum toxin injections in the treatment of piriformis syndrome.","volume":"96","author":"Al-Al-Shaikh","year":"2015","journal-title":"Diagn Interv Imaging"},{"key":"R5-20250504","article-title":"Prospective study evaluating incobotulinumtoxinA for cervical dystonia or blepharospasm: interim results from the first 145 subjects with cervical dystonia.","volume":"3","author":"Fernandez","year":"2013","journal-title":"Tremor Other Hyperkinet Mov (NY)"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1097\/00000542-200306000-00022","article-title":"Piriformis syndrome: anatomic considerations, a new injection technique, and a review of the literature.","volume":"98","author":"Benzon","year":"2003","journal-title":"Anesthesiology"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00256-008-0486-8","article-title":"Magnetic resonance imaging of the sacral plexus and piriformis muscles.","volume":"37","author":"Russell","year":"2008","journal-title":"Skeletal Radiol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/mus.25504","article-title":"Electrophysiologically identified piriformis syndrome is successfully treated with incobotulinum toxin a and physical therapy.","volume":"56","author":"Fishman","year":"2017","journal-title":"Muscle Nerve"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00002060-200210000-00006","article-title":"Botulinum toxin type A use in piriformis muscle syndrome: a pilot study.","volume":"81","author":"Childers","year":"2002","journal-title":"Am J Phys Med Rehabil"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3344\/kjp.2011.24.1.1","article-title":"Application of botulinum toxin in pain management.","volume":"24","author":"Sim","year":"2011","journal-title":"Korean J Pain"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1212\/WNL.56.10.1290","article-title":"Botulinum toxin A and chronic low back pain: a randomized, double-blind study.","volume":"56","author":"Foster","year":"2001","journal-title":"Neurology"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.7863\/jum.2008.27.8.1157","article-title":"Accuracy of ultrasound-guided versus fluoroscopically guided contrast-controlled piriformis injections: a cadaveric study.","volume":"27","author":"Finnoff","year":"2008","journal-title":"J Ultrasound Med"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"327","DOI":"10.36076\/ppj.2008\/11\/327","article-title":"Confirmation of needle placement within the piriformis muscle of a cadaveric specimen using anatomic landmarks and fluoroscopic guidance.","volume":"11","author":"Gonzalez","year":"2008","journal-title":"Pain Physician"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/mds.25582","article-title":"Diffusion, spread, and migration of botulinum toxin.","volume":"28","author":"Ramirez-Castaneda","year":"2013","journal-title":"Mov Disord"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1017\/S0012162203000380","article-title":"Effect of muscle activity and botulinum toxin dilution volume on muscle paralysis.","volume":"45","author":"Kim","year":"2003","journal-title":"Dev Med Child Neurol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/archderm.140.11.1351","article-title":"Effect of volume and concentration on the diffusion of botulinum exotoxin A.","volume":"140","author":"Hsu","year":"2004","journal-title":"Arch Dermatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030950","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:41:45Z","timestamp":1746333705000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":16,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030950","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]}}}